Reducing Vascular Risk in Patients Living with Diabetes

Determine which patients with diabetes require vascular protective therapy

About

This tool was developed based on the 2018 Diabetes Canada Clinical Practice Guidelines for the Prevention and Management of Diabetes. Published every five years, these guidelines represent the best and most current evidence-based clinical practice data for healthcare professionals.

Diabetes significantly accelerates the development and natural history of cardiovascular disease compared to individuals without diabetes. Healthy behaviour interventions and pharmacological approaches aimed at cardiovascular disease risk reduction can significantly reduce morbidity and mortality, and are an important cornerstone of the management of diabetes.

References

Stone, J. A., Houlden, R. L., Lin, P., Udell, J. A., Verma, S.

Cardiovascular Protection in People With Diabetes.

Canadian Journal of Diabetes 2018, 42 Suppl 1: S162-S169

Created by on 07/01/2016

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. Cardiovascular Disease?

More Information

• Angina; previous MI; previous PTCI; previous CABG

• Peripheral artery disease: claudication, peripheral bypass

• Cerebrovascular disease: TIA, CVA

0/7 completed